July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
The Lipoxin LXB4 Reduces Mitochondrial Oxidative Stress in Retinal Ganglion Cells
Author Affiliations & Notes
  • izhar Livne-bar
    University Health Network-Krembil Discovery Inst., Toronto, Ontario, Canada
  • John G Flanagan
    School of Optometry, University of California at Berkeley, Berkeley, California, United States
  • Karsten Gronert
    School of Optometry, University of California at Berkeley, Berkeley, California, United States
  • Jeremy M Sivak
    University Health Network-Krembil Discovery Inst., Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   izhar Livne-bar, None; John Flanagan, None; Karsten Gronert, None; Jeremy Sivak, None
  • Footnotes
    Support  CIHR, NSERC
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 620. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      izhar Livne-bar, John G Flanagan, Karsten Gronert, Jeremy M Sivak; The Lipoxin LXB4 Reduces Mitochondrial Oxidative Stress in Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2019;60(9):620.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The small lipid mediators LXA4 and LXB4 promote retinal ganglion cells (RGC) survival following acute metabolic stress and sustained IOP insult. However, the mechanism underlying this effect is still unclear. We report here that LXB4 treatment can reduce markers of mitochondrial oxidative stress in RGCs following acute metabolic and oxidative injury in vivo, and in neuronal cultures.

Methods : Retinal acute metabolic stress was generated by intravitreal injections of Kainic acid (KA). RGC survival was quantified using specific antibodies. Inner retinal mitochondrial oxidative stress was assessed by measuring superoxide dismutase 2 (SOD2) induction. Oxidative stress in neuronal cell culture was induced by Paraquat and cell survival quantified by XTT assay. In parallel, mitochondrial oxidative stress in these cultures was assessed using Mitosox assay.

Results : We show that intravitreal LXB4 treatment strongly increases RGC survival following metabolic injury by 99.3%. In addition, this LXB4 treatment reduces RGC mitochondrial stress, as indicated by significantly reduced SOD2 levels (59.9%). Similarly, direct LXB4 treatment of cultured neurons increases survival from oxidative-stress insult by 56.2%, and reduces the mitochondrial oxidative stress signal by 75%.

Conclusions : These results suggest that the retinal protective effect of the lipoxin LXB4 is mediated, at least in part, by reducing mitochondrial oxidative stress. We are currently investigating the signaling pathway mediating the LXB4 effect on mitochondrial stress responses, and are assessing whether LXB4 promotes a similar mitochondrial resilience in a chronic, IOP-induced injury model.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×